As of November 6, 2026, Satellos Bioscience Inc. is a publicly traded company (Nasdaq: MSLE); its largest reported holder is Qiming U.S. Healthcare Fund III, L.P., with 8.3% on Schedule 13G of May 12, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings. Founder or officer holdings: Brian Bloom, a director (7.35%, reporting on Schedule 13G) (Schedule 13G, May 12, 2026).
Is this your company?
About to sign with, pay or invest in Satellos Bioscience Inc.? See the free Snapshot first.
Free to see. No signup.
Is Satellos Bioscience Inc. a real, registered company?
- Satellos Bioscience Inc. files with the SEC under CIK 1421642 (its SEC filings).
- Its shares are listed under the ticker MSLE on Nasdaq (SEC company record).
- Incorporated in Z4, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Satellos Bioscience Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Brian Matthew Bloom (filed 2026-05-15).
Who are Satellos Bioscience Inc.'s owners and officers?
Satellos Bioscience Inc.: industry Pharmaceutical Preparations (Schedule 13G, 2026-05-15).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director, Promoter (Form D, 2025-01-03)
- : Executive Officer (Form D, 2025-01-03)
- : Executive Officer (Form D, 2025-01-03)
- : Director (Form D, 2025-01-03)
- : Director (Form D, 2025-01-03)
- : Director (Form D, 2025-01-03)
- : Director (Form D, 2025-01-03)
- : Director (Form D, 2025-01-03)
- : Director (Form D, 2025-01-03)
- : Executive Officer (Form D, 2025-01-03)
- : Executive Officer (Form D, 2025-01-03)
- : Executive Officer (Form D, 2025-01-03)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-05-15 | Brian Matthew Bloom | 7.35% |
| Schedule 13G, 2026-05-12 | Qiming U.S. Healthcare Fund Iii, L.P. | 8.3% |
Questions about who owns Satellos Bioscience Inc.
Who owns Satellos Bioscience Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Satellos Bioscience Inc.: Qiming U.S. Healthcare Fund Iii, L.P. (8.3%, Schedule 13G, filed 2026-05-12) and Brian Matthew Bloom (7.35%, Schedule 13G, filed 2026-05-15).
Who are the largest shareholders of Satellos Bioscience Inc.?
By the share each holder's latest filing reports, the largest holders of Satellos Bioscience Inc. on this page are Qiming U.S. Healthcare Fund Iii, L.P. (8.3%) and Brian Matthew Bloom (7.35%).
When did Qiming U.S. Healthcare Fund Iii, L.P. buy into Satellos Bioscience Inc.?
The filings give report dates, not purchase dates. The earliest filing from Qiming U.S. Healthcare Fund Iii, L.P. on this page is the Schedule 13G, filed 2026-05-12, reporting 8.3%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Satellos Bioscience Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Satellos Bioscience Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Satellos Bioscience Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
How much has Satellos Bioscience Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-01-03 | $25.02M | $25.02M |
| Form D, 2023-05-25 | $33.29M | $33.29M |
Keep reading
More on Satellos Bioscience Inc. and the records around it.
Satellos Bioscience Inc. elsewhere on the record
- 5%+ stake filings May 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/satellos-bioscience